Cargando…
(1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism
BACKGROUND: The liver fluke Opisthorchis viverrini (OV), which subsequently inhabits the biliary system and results in periductal fibrosis (PDF), is one of the primarily causes of cholangiocarcinoma (CCA), a bile duct cancer with an exceptionally high incidence in the northeast of Thailand and other...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178365/ https://www.ncbi.nlm.nih.gov/pubmed/37187520 http://dx.doi.org/10.7717/peerj.15386 |
_version_ | 1785040844548472832 |
---|---|
author | Treeriya, Rujikorn Ho, Phuc N. Titapun, Attapol Klanrit, Poramate Suksawat, Manida Kulthawatsiri, Thanaporn Sirirattanakul, Suphasarang Loilome, Watcharin Namwat, Nisana Wangwiwatsin, Arporn Chamadol, Nittaya Khuntikeo, Narong Phetcharaburanin, Jutarop |
author_facet | Treeriya, Rujikorn Ho, Phuc N. Titapun, Attapol Klanrit, Poramate Suksawat, Manida Kulthawatsiri, Thanaporn Sirirattanakul, Suphasarang Loilome, Watcharin Namwat, Nisana Wangwiwatsin, Arporn Chamadol, Nittaya Khuntikeo, Narong Phetcharaburanin, Jutarop |
author_sort | Treeriya, Rujikorn |
collection | PubMed |
description | BACKGROUND: The liver fluke Opisthorchis viverrini (OV), which subsequently inhabits the biliary system and results in periductal fibrosis (PDF), is one of the primarily causes of cholangiocarcinoma (CCA), a bile duct cancer with an exceptionally high incidence in the northeast of Thailand and other Greater Mekong Subregion (GMS) countries. Insights in fecal metabolic changes associated with PDF and CCA are required for further molecular research related to gut health and potential diagnostic biological marker development. METHODS: In this study, nuclear magnetic resonance (NMR) metabolomics was applied for fecal metabolic phenotyping from 55 fecal water samples across different study groups including normal bile duct, PDF and CCA groups. RESULTS: By using NMR spectroscopy-based metabolomics, fecal metabolic profiles of patients with CCA or PDF and of individuals with normal bile duct have been established with a total of 40 identified metabolites. Further multivariate statistical analysis and hierarchical clustering heat map have demonstrated the PDF- and CCA-specific metabotypes through various altered metabolite groups including amino acids, alcohols, amines, anaerobic glycolytic metabolites, fatty acids, microbial metabolites, sugar, TCA cycle intermediates, tryptophan catabolism substrates, and pyrimidine metabolites. Compared to the normal bile duct group, PDF individuals showed the significantly elevated relative concentrations of fecal ethanol, glycine, tyrosine, and N-acetylglucosamine whereas CCA patients exhibited the remarkable fecal metabolic changes that can be evident through the increased relative concentrations of fecal uracil, succinate, and 5-aminopentanoate. The prominent fecal metabolic alterations between CCA and PDF were displayed by the reduction of relative concentration of methanol observed in CCA. The metabolic alterations associated with PDF and CCA progression have been proposed with the involvement of various metabolic pathways including TCA cycle, ethanol biogenesis, hexamine pathway, methanol biogenesis, pyrimidine metabolism, and lysine metabolism. Among them, ethanol, methanol, and lysine metabolism strongly reflect the association of gut-microbial host metabolic crosstalk in PDF and/or CCA patients. CONCLUSION: The PDF- and CCA-associated metabotypes have been investigated displaying their distinct fecal metabolic patterns compared to that of normal bile duct group. Our study also demonstrated that the perturbation in co-metabolism of host and gut bacteria has been involved from the early step since OV infection to CCA tumorigenesis. |
format | Online Article Text |
id | pubmed-10178365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101783652023-05-13 (1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism Treeriya, Rujikorn Ho, Phuc N. Titapun, Attapol Klanrit, Poramate Suksawat, Manida Kulthawatsiri, Thanaporn Sirirattanakul, Suphasarang Loilome, Watcharin Namwat, Nisana Wangwiwatsin, Arporn Chamadol, Nittaya Khuntikeo, Narong Phetcharaburanin, Jutarop PeerJ Biochemistry BACKGROUND: The liver fluke Opisthorchis viverrini (OV), which subsequently inhabits the biliary system and results in periductal fibrosis (PDF), is one of the primarily causes of cholangiocarcinoma (CCA), a bile duct cancer with an exceptionally high incidence in the northeast of Thailand and other Greater Mekong Subregion (GMS) countries. Insights in fecal metabolic changes associated with PDF and CCA are required for further molecular research related to gut health and potential diagnostic biological marker development. METHODS: In this study, nuclear magnetic resonance (NMR) metabolomics was applied for fecal metabolic phenotyping from 55 fecal water samples across different study groups including normal bile duct, PDF and CCA groups. RESULTS: By using NMR spectroscopy-based metabolomics, fecal metabolic profiles of patients with CCA or PDF and of individuals with normal bile duct have been established with a total of 40 identified metabolites. Further multivariate statistical analysis and hierarchical clustering heat map have demonstrated the PDF- and CCA-specific metabotypes through various altered metabolite groups including amino acids, alcohols, amines, anaerobic glycolytic metabolites, fatty acids, microbial metabolites, sugar, TCA cycle intermediates, tryptophan catabolism substrates, and pyrimidine metabolites. Compared to the normal bile duct group, PDF individuals showed the significantly elevated relative concentrations of fecal ethanol, glycine, tyrosine, and N-acetylglucosamine whereas CCA patients exhibited the remarkable fecal metabolic changes that can be evident through the increased relative concentrations of fecal uracil, succinate, and 5-aminopentanoate. The prominent fecal metabolic alterations between CCA and PDF were displayed by the reduction of relative concentration of methanol observed in CCA. The metabolic alterations associated with PDF and CCA progression have been proposed with the involvement of various metabolic pathways including TCA cycle, ethanol biogenesis, hexamine pathway, methanol biogenesis, pyrimidine metabolism, and lysine metabolism. Among them, ethanol, methanol, and lysine metabolism strongly reflect the association of gut-microbial host metabolic crosstalk in PDF and/or CCA patients. CONCLUSION: The PDF- and CCA-associated metabotypes have been investigated displaying their distinct fecal metabolic patterns compared to that of normal bile duct group. Our study also demonstrated that the perturbation in co-metabolism of host and gut bacteria has been involved from the early step since OV infection to CCA tumorigenesis. PeerJ Inc. 2023-05-09 /pmc/articles/PMC10178365/ /pubmed/37187520 http://dx.doi.org/10.7717/peerj.15386 Text en © 2023 Treeriya et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Biochemistry Treeriya, Rujikorn Ho, Phuc N. Titapun, Attapol Klanrit, Poramate Suksawat, Manida Kulthawatsiri, Thanaporn Sirirattanakul, Suphasarang Loilome, Watcharin Namwat, Nisana Wangwiwatsin, Arporn Chamadol, Nittaya Khuntikeo, Narong Phetcharaburanin, Jutarop (1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism |
title | (1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism |
title_full | (1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism |
title_fullStr | (1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism |
title_full_unstemmed | (1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism |
title_short | (1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism |
title_sort | (1)h nmr fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism |
topic | Biochemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178365/ https://www.ncbi.nlm.nih.gov/pubmed/37187520 http://dx.doi.org/10.7717/peerj.15386 |
work_keys_str_mv | AT treeriyarujikorn 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism AT hophucn 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism AT titapunattapol 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism AT klanritporamate 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism AT suksawatmanida 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism AT kulthawatsirithanaporn 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism AT sirirattanakulsuphasarang 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism AT loilomewatcharin 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism AT namwatnisana 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism AT wangwiwatsinarporn 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism AT chamadolnittaya 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism AT khuntikeonarong 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism AT phetcharaburaninjutarop 1hnmrfecalmetabolicphenotypingofperiductalfibrosisandcholangiocarcinomaspecificmetabotypesdefiningperturbationingutmicrobialhostcometabolism |